Yue Yan

MOE Key Laboratory Of Macromolecule Synthesis And Functionalization
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Anion-π Interaction-Triggered Self-Healing Zwitterionic Hydrogel as an Immunocompatible Platform for Injectable Therapies.

Anion-π Interaction-Triggered Self-Healing Zwitterionic Hydrogel as an Immunocompatible Platform for Injectable Therapies.

Journal: Advanced healthcare materials

Published: April 19, 2026

Accelerated biological aging (GOLD BioAgeDiff) and depressive symptoms in US adults: NHANES 2005-2018.

Accelerated biological aging (GOLD BioAgeDiff) and depressive symptoms in US adults: NHANES 2005-2018.

Journal: Journal of affective disorders

Published: December 26, 2025

An Immunocompatible Conductive Hydrogel Via Anion-π Interlocking as an Injectable Bridge for Sustained Bioelectronic Interfacing.

An Immunocompatible Conductive Hydrogel Via Anion-π Interlocking as an Injectable Bridge for Sustained Bioelectronic Interfacing.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: December 09, 2025

Value of creatine kinase and creatinine as biomarkers in nusinersen-treated children with spinal muscular atrophy.

Value of creatine kinase and creatinine as biomarkers in nusinersen-treated children with spinal muscular atrophy.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: June 30, 2025

A Sprayable Polyelectrolyte Coating to Mitigate the Foreign Body Response of Implants.

A Sprayable Polyelectrolyte Coating to Mitigate the Foreign Body Response of Implants.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: March 27, 2025

Longitudinal efficacy of risdiplam treatment in Chinese children with spinal muscular atrophy.

Longitudinal efficacy of risdiplam treatment in Chinese children with spinal muscular atrophy.

Journal: Orphanet journal of rare diseases

Published: December 11, 2024

Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study.

Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study.

Journal: Muscle & nerve

Published: October 08, 2024

Health information literacy among children with spinal muscular atrophy and their caregivers.

Health information literacy among children with spinal muscular atrophy and their caregivers.

Journal: Italian journal of pediatrics

Published: May 21, 2024

Longitudinal Efficacy of Nusinersen Treatment on Health-Related Quality of Life and Independence in Children With Later-Onset Spinal Muscular Atrophy.

Longitudinal Efficacy of Nusinersen Treatment on Health-Related Quality of Life and Independence in Children With Later-Onset Spinal Muscular Atrophy.

Journal: Muscle & nerve

Published: April 23, 2024

Analytical validation of the amplification refractory mutation system polymerase chain reaction-capillary electrophoresis assay to diagnose spinal muscular atrophy.

Analytical validation of the amplification refractory mutation system polymerase chain reaction-capillary electrophoresis assay to diagnose spinal muscular atrophy.

Journal: Clinical chemistry and laboratory medicine

Published: March 12, 2024

Safety of risdiplam in spinal muscular atrophy patients after short-term treatment with nusinersen.

Safety of risdiplam in spinal muscular atrophy patients after short-term treatment with nusinersen.

Journal: Muscle & nerve

Published: January 30, 2024

Impact of Nusinersen Treatment on the Independence and Mental Health of School-Aged Patients With Spinal Muscular Atrophy.

Impact of Nusinersen Treatment on the Independence and Mental Health of School-Aged Patients With Spinal Muscular Atrophy.

Journal: Pediatric neurology

Published: January 16, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026